Literature DB >> 19267699

Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.

Nienke Jabben1, Baer Arts, Lydia Krabbendam, Jim van Os.   

Abstract

OBJECTIVES: In schizophrenia, a distinction is made between psychosis with developmental and cognitive impairment on the one hand and psychosis without developmental impairment and positive symptoms on the other. In this study, we investigated whether this model can be extended to bipolar disorder by testing the hypothesis that neurocognitive functioning is inversely related to positive psychotic symptoms in bipolar disorder.
METHODS: Neurocognitive functioning and psychopathology were assessed in (i) 76 patients with bipolar disorder, (ii) 39 of their healthy first-degree relatives, and (iii) 61 healthy controls. Cognitive performance of bipolar patients and their first-degree relatives was investigated, taking into account the possible moderating effect of the level of expression of psychosis in patients and relatives.
RESULTS: Bipolar patients showed impaired cognitive performance on multiple cognitive domains, whereas performance of their relatives was comparable to that of controls. A history of psychotic symptoms in patients was suggestive of less likelihood of cognitive alterations in relatives, and the presence of subclinical psychotic symptoms within the group of relatives predicted better cognitive performance.
CONCLUSIONS: The finding of similar psychosis-cognition associations in bipolar disorder as implied by the two pathways leading to nonaffective psychotic disorders suggests that this model might be extended to the continuum spanning affective and nonaffective psychosis. This is in line with the idea of a partially overlapping vulnerability to bipolar disorder and schizophrenia and provides an explanation for the apparent differences in cognitive alterations in those at risk for the two disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19267699     DOI: 10.1111/j.1399-5618.2009.00663.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  7 in total

1.  Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives.

Authors:  Shashwath A Meda; Adrienne Gill; Michael C Stevens; Raymond P Lorenzoni; David C Glahn; Vince D Calhoun; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan; Gunvant Thaker; Godfrey D Pearlson
Journal:  Biol Psychiatry       Date:  2012-03-07       Impact factor: 13.382

2.  Cognitive endophenotypes of psychosis within dimension and diagnosis.

Authors:  Elena I Ivleva; David W Morris; Julian Osuji; Amanda F Moates; Thomas J Carmody; Gunvant K Thaker; Munro Cullum; Carol A Tamminga
Journal:  Psychiatry Res       Date:  2012-02-18       Impact factor: 3.222

Review 3.  Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences.

Authors:  Deanna M Barch
Journal:  Curr Psychiatry Rep       Date:  2009-08       Impact factor: 5.285

4.  The neurocognitive functioning in bipolar disorder: a systematic review of data.

Authors:  Eirini Tsitsipa; Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2015-12-01       Impact factor: 3.455

5.  Realising stratified psychiatry using multidimensional signatures and trajectories.

Authors:  Dan W Joyce; Angie A Kehagia; Derek K Tracy; Jessica Proctor; Sukhwinder S Shergill
Journal:  J Transl Med       Date:  2017-01-18       Impact factor: 5.531

6.  Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val108/158 Met genotype.

Authors:  Baer Arts; Claudia J P Simons; Marjan Drukker; Jim van Os
Journal:  BMC Psychiatry       Date:  2013-02-19       Impact factor: 3.630

7.  Cognitive impairment in bipolar disorder and schizophrenia: a systematic review.

Authors:  Paul A Vöhringer; Sergio A Barroilhet; Andrea Amerio; Maria Laura Reale; Katherine Alvear; Derick Vergne; S Nassir Ghaemi
Journal:  Front Psychiatry       Date:  2013-08-08       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.